Form 8-K - Current report:
SEC Accession No. 0001477932-25-004827
Filing Date
2025-06-27
Accepted
2025-06-27 10:48:51
Documents
17
Period of Report
2025-06-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K thct_8k.htm   iXBRL 8-K 26232
2 CERTIFICATE OF DESIGNATION thct_ex31.htm EX-3.1 24407
3 ACQUISITION AGREEMENT thct_ex101.htm EX-10.1 288390
4 PRESS RELEASE thct_ex991.htm EX-99.1 21638
  Complete submission text file 0001477932-25-004827.txt   537451

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA thct-20250620.xsd EX-101.SCH 5874
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE thct-20250620_lab.xml EX-101.LAB 12618
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE thct-20250620_cal.xml EX-101.CAL 898
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thct-20250620_pre.xml EX-101.PRE 7881
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE thct-20250620_def.xml EX-101.DEF 2099
19 EXTRACTED XBRL INSTANCE DOCUMENT thct_8k_htm.xml XML 3413
Mailing Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135
Business Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135 833-420-8428
THC Therapeutics, Inc. (Filer) CIK: 0001404935 (see all company filings)

EIN.: 260164981 | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-55994 | Film No.: 251083178
SIC: 3523 Farm Machinery & Equipment
(CF Office: 06 Technology)